BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 24583754)

  • 1. Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease.
    Singh P; Kurray L; Agnihotri A; Das P; Verma AK; Sreenivas V; Dattagupta S; Makharia GK
    J Clin Gastroenterol; 2015 Mar; 49(3):212-7. PubMed ID: 24583754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease.
    Alessio MG; Tonutti E; Brusca I; Radice A; Licini L; Sonzogni A; Florena A; Schiaffino E; Marus W; Sulfaro S; Villalta D;
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):44-9. PubMed ID: 22197946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of no-biopsy pathway for the diagnosis of celiac disease in Asian adults: a multicenter retrospective study.
    Pachisia AV; Kumari A; Mehta S; Ahmed A; Chauhan A; Agarwal A; Dwarkanathan V; Rajpoot S; Prasad S; Kumar S; Sinha SK; Sharma D; Rajput M; Das P; Falodia S; Kochhar R; Ramakrishna BS; Ahuja V; Makharia G
    J Gastroenterol Hepatol; 2024 Mar; 39(3):489-495. PubMed ID: 38095156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
    Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
    Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
    Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
    Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease.
    Bhattacharya M; Lomash A; Sakhuja P; Dubey AP; Kapoor S
    Indian J Gastroenterol; 2014 Jul; 33(4):350-4. PubMed ID: 24859392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Immunologic Features of Ultra-Short Celiac Disease.
    Mooney PD; Kurien M; Evans KE; Rosario E; Cross SS; Vergani P; Hadjivassiliou M; Murray JA; Sanders DS
    Gastroenterology; 2016 May; 150(5):1125-1134. PubMed ID: 26836585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of celiac disease in Indian patients with irritable bowel syndrome and uninvestigated dyspepsia.
    Sharma H; Verma AK; Das P; Dattagupta S; Ahuja V; Makharia GK
    J Dig Dis; 2015 Aug; 16(8):443-8. PubMed ID: 25959064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
    Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
    Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
    Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.
    Auricchio R; Mandile R; Del Vecchio MR; Scapaticci S; Galatola M; Maglio M; Discepolo V; Miele E; Cielo D; Troncone R; Greco L
    Gastroenterology; 2019 Aug; 157(2):413-420.e3. PubMed ID: 30978358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy.
    Tortora R; Imperatore N; Capone P; De Palma GD; De Stefano G; Gerbino N; Caporaso N; Rispo A
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1223-9. PubMed ID: 25263177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
    Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
    Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease.
    Choung RS; Khaleghi Rostamkolaei S; Ju JM; Marietta EV; Van Dyke CT; Rajasekaran JJ; Jayaraman V; Wang T; Bei K; Rajasekaran KE; Krishna K; Krishnamurthy HK; Murray JA
    Gastroenterology; 2019 Feb; 156(3):582-591.e1. PubMed ID: 30342033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
    Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
    World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.